14.95Open14.95Pre Close0 Volume3 Open Interest65.00Strike Price0.00Turnover3741.85%IV-0.36%PremiumDec 27, 2024Expiry Date15.24Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9861Delta0.0045Gamma5.23Leverage Ratio-50.5585Theta0.0000Rho5.15Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet